Alpha Healthcare III (NASDAQ:ALPA) announced in an 8-K this morning that it has signed a forward purchase agreement (FPA) and a non-redemption agreement to support its combination with biotech firm Carmell.
Meteora Special Opportunity Fund I has agreed to purchase an amount of shares equal to 9.5% of ordinary Alpha Healthcare III stock at close through the FPA. It will be prepaid for these purchases at its redemption price out of funds from Alpha Healthcare III’s trust.
The investor may then sell these shares and terminate the agreements coverage of them at a price equal to the combined company’s VWAP at the beginning of a given week, but this is subject to a floor of $11.50. Otherwise, the agreement is to settle one year after close at the price of the time, but Meteora is to pay a $0.50 fee per share held up to this point.
Meteora has also agreed to not redeem 100,000 other shares that it currently holds.
This all comes as Alpha Healthcare III goes into a vote to complete its combination with Carmell tomorrow, July 11. The two sides initially agreed to their $188 million merger in January. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds.
The deal does not include a minimum cash condition beyond the $5 million needed to maintain listing requirements. But, in late June, Alpha Healthcare III announced it had signed a non-binding LOI for Carmell to acquire a commercial-stage biotech firm for about $65 million post-close.
Under the current non-binding terms of the LOI, the post-close company would need to pay about $8 million of the compensation for this acquisition in cash.


Pyrophyte II (NYSE:PAII.U) has filed for a $175 million SPAC to dig for a natural resources target while the team’s first deal remains pending. The new SPAC is offering investors 1/2 warrants in each unit and it will have 24 months to complete a business combination without asking shareholders for an extension. It is the...
At the SPAC of Dawn The last day of the quarter is to play host to a pair of shareholder votes and a possible pricing of Indigo‘s (NASDAQ:INACU) $100 million IPO. This week is also to play host to fresh jobs numbers just before the long July 4 weekend. Black Hawk (NASDAQ:BKHA) was also one...
Terms Tracker for the Week Ending June 27, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. June continued its late-month rally with another five SPAC IPOs pricing this week, bringing the monthly total to 10 and the 2025 year-to-date count to...
Blueport (NASDAQ:BPACU) has filed for a $69 million SPAC that would bring another first-time sponsor team to market. The new SPAC is offering investors a right to a 1/6 share in each unit and it will have 15 months to complete a business combination. It is underwritten by Alliance Global Partners and will not be...
At the SPAC of Dawn The markets appear to poised to continue a rosy week with futures in the green in anticipation of PCE inflation readings. Space is one of the sectors feeling the most love recently and launch services firm Rocket Lab (NASDAQ:RKLB) is keeping up the momentum, scheduling two launches within 48 hours...